Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Deferred Taxes: 2022-2025

Historic Deferred Taxes for GeneDx Holdings (WGS) over the last 4 years, with Sep 2025 value amounting to $246,000.

  • GeneDx Holdings' Deferred Taxes rose 623.40% to $246,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $424,000, marking a year-over-year increase of 158.08%. This contributed to the annual value of -$343,000 for FY2024, which is 62.96% up from last year.
  • Latest data reveals that GeneDx Holdings reported Deferred Taxes of $246,000 as of Q3 2025, which was up 200.41% from -$245,000 recorded in Q2 2025.
  • GeneDx Holdings' 5-year Deferred Taxes high stood at $447,000 for Q1 2025, and its period low was -$49.1 million during Q2 2022.
  • Over the past 3 years, GeneDx Holdings' median Deferred Taxes value was -$147,000 (recorded in 2023), while the average stood at -$74,636.
  • Its Deferred Taxes has fluctuated over the past 5 years, first tumbled by 890.38% in 2023, then surged by 645.12% in 2025.
  • Quarterly analysis of 4 years shows GeneDx Holdings' Deferred Taxes stood at $52,000 in 2022, then crashed by 890.38% to -$411,000 in 2023, then skyrocketed by 94.16% to -$24,000 in 2024, then surged by 623.40% to $246,000 in 2025.
  • Its Deferred Taxes was $246,000 in Q3 2025, compared to -$245,000 in Q2 2025 and $447,000 in Q1 2025.